Skip to main content
SpringerLink
Log in
Book cover

Molecular Genetic Pathology pp 133–140Cite as

Tissue Microarrays and Biomarker Validation

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  • Berman JJ, Datta M, Kajdacsy-Balla A, et al. The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource. BMC Bioinformatics 2004;5:19.

    Article  PubMed  Google Scholar 

  • Bolli M, Schultz-Thater E, Zajac P, et al. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study. Int J Cancer 2005;115:960–966.

    Article  CAS  PubMed  Google Scholar 

  • Bubendorf L, Kolmer M, Kononen J, et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst. 1999;91:1758–1764.

    Article  CAS  PubMed  Google Scholar 

  • Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hydridization on tissue microarrays. Cancer Res. 1999;59:803–806.

    CAS  PubMed  Google Scholar 

  • Bubendorf L, Nocito A, Moch H, et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol. 2001;195:72–79 (review article).

    Article  CAS  PubMed  Google Scholar 

  • Chung GG, Yoon HH, Zerkowski MP, et al. Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray. Cancer 2006;106:1677–1684.

    Article  CAS  PubMed  Google Scholar 

  • Dell’Anna R, Demichelis F, Barbareschi M, et al. An automated procedure to properly handle digital images in large scale tissue microarray experiments. Comput Methods Programs Biomed. 2005;79:197–208.

    Article  Google Scholar 

  • Diaz LK, Gupta R, Kidwai N, et al. The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer. J Histochem Cytochem. 2004;52:501–507.

    CAS  PubMed  Google Scholar 

  • Fowler JM, Ramirez N Cohn DE, et al. Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis. Am J Obstet Gynecol. 2005;192:1262–1271; discussion 1271–1273.

    Article  CAS  PubMed  Google Scholar 

  • Garcia JF, Camacho FI, Morente M, et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2003;101:681–689.

    Article  CAS  PubMed  Google Scholar 

  • Gulmann C, Loring P, O’Grady A, et al. Miniature tissue microarrays for Hercep Test standardisation and analysis. J Clin Pathol. 2004;57:1229–1231.

    Article  CAS  PubMed  Google Scholar 

  • Hendriks Y, Franken P, Dierssen JW, et al. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol. 2003;162:469–477.

    CAS  PubMed  Google Scholar 

  • Howard BA, Zheng Z, Campa MJ, et al. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer. Lung Cancer 2004;46:313–323.

    Article  PubMed  Google Scholar 

  • Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001; 10:657–662 (review article).

    Article  CAS  PubMed  Google Scholar 

  • Kay E, O’Grady A, Morgan JM, et al. Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing. J Clin Pathol. 2004;57:1140–1144.

    Article  CAS  PubMed  Google Scholar 

  • Kettunen E, Nicholson AG, Nagy B, et al. L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray Carcinogenesis 2005;26: 17–25.

    Article  CAS  PubMed  Google Scholar 

  • Kim R, Demichelis F, Tang J, et al. Internet-based Profiler system as integrative framework to support translational research. BMC Bioinformatics 2005;6:304.

    Article  PubMed  Google Scholar 

  • Kocher T, Zheng M, Bolli M, et al. Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Int J Cancer 2002;100:702–705.

    Article  CAS  PubMed  Google Scholar 

  • Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998; 4:844–847.

    Article  CAS  PubMed  Google Scholar 

  • Koynova DK, Tsenova VS, Jankova RS, et al. Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx. J Cancer Res Clin Oncol. 2005;131:199–203.

    Article  CAS  PubMed  Google Scholar 

  • Kuefer R, Hofer MD, Gschwend JE, et al. Tissue microarrays. High-throughput procedures to verify potential biomarkers. Urologe A. 2004;43:659–667 (review article).

    CAS  PubMed  Google Scholar 

  • Linke SP, Bremer TM, Herold CD, et al. A multimarker model to predict outcome in tamoxifen-treated breast cancer patients. Clin Cancer Res. 2006;12:1175–1183.

    Article  CAS  PubMed  Google Scholar 

  • Liu CL, Montgomery KD, Natkunam Y, et al. TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays. Mod Pathol. 2005;18:1641–1648 (review article).

    CAS  PubMed  Google Scholar 

  • Liu X, Minin V, Huang Y, et al. Statistical methods for analyzing tissue microarray data. J Biopharm Stat. 2004;14:671–685 (review article).

    Article  PubMed  Google Scholar 

  • Lusis EA, Chicoine MR, Perry A. High throughput screening of meningioma biomarkers using a tissue microarray. J Neurooncol. 2005;73:219–223.

    Article  CAS  PubMed  Google Scholar 

  • Manley S, Mucci NR, De Marzo AM, et al. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model. Am J Pathol. 2001;159:837–843 (review article).

    CAS  PubMed  Google Scholar 

  • Mengel M, Kreipe H, von Wasielewski R. Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems. Appl Immunohistochem Mol Morphol. 2003;11:261–268 (review article).

    CAS  PubMed  Google Scholar 

  • Mirlacher M, Kasper M, Storz M, et al. Influence of slide aging on results of translational research studies using immunohistochemistry. Mod Pathol. 2004;17:1414–1420.

    Article  PubMed  Google Scholar 

  • Moch H, Kononen T, Kallioniemi OP, et al. Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol. 2001; 8:14–20 (review article).

    Article  CAS  PubMed  Google Scholar 

  • Moch H, Schraml P, Bubendorf L, et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol. 1999;154:981–986.

    CAS  PubMed  Google Scholar 

  • Nielsen TO, Hsu FD, O’Connell JX, et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol. 2003; 163:1449–1456.

    CAS  PubMed  Google Scholar 

  • Nocito A, Bubendorf L, Tinner EM, et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol. 2001;194:349–357.

    Article  CAS  PubMed  Google Scholar 

  • Packeisen J, Korsching E, Herbst H, et al. Demystified tissue microarray technology. Mol Pathol. 2003;56:198–204 (review article).

    Article  CAS  PubMed  Google Scholar 

  • Rubin MA, Dunn R, Strawderman M, et al. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol. 2002;26:312–319.

    Article  PubMed  Google Scholar 

  • Rubin MA, Mucci NR, Figurski J, et al. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Hum Pathol. 2001;32:690–697.

    Article  CAS  PubMed  Google Scholar 

  • Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res. 1999;5:1966–1975.

    CAS  PubMed  Google Scholar 

  • Schraml P, Schwerdtfeger G, Burkhalter F, et al. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol. 2003;163:985–992.

    CAS  PubMed  Google Scholar 

  • Simon R, Sauter G. Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp Hematol. 2002;30:1365–1372 (review article).

    Article  CAS  PubMed  Google Scholar 

  • Simon R, Sauter G. Tissue microarray (TMA) applications: implications for molecular medicine. Expert Rev Mol Med. 2003;2003;1–12 (review article).

    Google Scholar 

  • Simon R, Mirlacher M, Sauter G. Tissue microarrays. Methods Mol Med. 2005;114:257–268 (review article).

    CAS  PubMed  Google Scholar 

  • Staller P, Sulitkova J, Lisztwan J, et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003;425:307–311.

    Article  CAS  PubMed  Google Scholar 

  • Struckmann K, Schraml P, Simon R, et al. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res. 2004;64:1632–1638.

    Article  CAS  PubMed  Google Scholar 

  • Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol. 2001; 159:2249–2256.

    CAS  PubMed  Google Scholar 

  • Tzankov A, Pehrs AC, Zimpfer A, et al. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases. J Clin Pathol. 2003;56:747–752.

    Article  CAS  PubMed  Google Scholar 

  • Tzankov A, Zimpfer A, Lugli A, et al. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin’s lymphoma indicates overexpression of cyclin E1. J Pathol 2003;199:201–207.

    Article  CAS  PubMed  Google Scholar 

  • Varga Z, Theurillat JP, Filonenko, V, et al. Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases. Clin Cancer Res.. 2006;12:2745–2751.

    Article  CAS  PubMed  Google Scholar 

  • Went P, Vasei M, Bubendorf L, et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 2006;94:128–135.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Surgical Pathology Department of Pathology, University Hospital Zürich, Zürich, Switzerland

    Martina Storz BS (Director of TMA Core Facility) & Holger Moch MD (Professor and Chairman)

Authors
  1. Martina Storz BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Holger Moch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine and Clarian Pathology Laboratory, Indiana University School of Medicine, Indianapolis, IN

    Liang Cheng MD (Professor of Pathology and Urology, Director of Molecular Pathology Laboratory, Chief of Genitourinary Pathology Division) (Professor of Pathology and Urology, Director of Molecular Pathology Laboratory, Chief of Genitourinary Pathology Division)

  2. Department of Pathology, Mount Sinai School of Medicine, New York, NY

    David Y. Zhang MD, PhD, MPH (Associate Professor of Pathology Director, Molecular Pathology Laboratory) (Associate Professor of Pathology Director, Molecular Pathology Laboratory)

  3. Mount Sinai Medical Center, New York, NY

    David Y. Zhang MD, PhD, MPH (Associate Professor of Pathology Director, Molecular Pathology Laboratory) (Associate Professor of Pathology Director, Molecular Pathology Laboratory)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Storz, M., Moch, H. (2008). Tissue Microarrays and Biomarker Validation. In: Cheng, L., Zhang, D.Y. (eds) Molecular Genetic Pathology. Humana Press. https://doi.org/10.1007/978-1-59745-405-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-405-6_4

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-974-1

  • Online ISBN: 978-1-59745-405-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation